Key Market Indicators
Estonian antacid medicine sales are set to reach $750,000 by 2026, up from $660,000 in 2021. This growth amounts to a 2.3% annual increase. Since 2004, the Estonian market has seen a 10.5% year-on-year growth. In 2021, the country ranked 19th in the world. Latvia came in ahead with $660,000 in sales. Italy, Germany, and Chile were the top three countries, in that order.
